Tuesday, 13th October 9th Venoms to Drugs 2026
Enquiries Desk
Session 5: Discovery
Morning Tea
Session 6: Rapid Fire
- Exploring arachnid venom peptides for biocontrol of pest snails - Yachen Wang
- Investigating the Role of Kv1.3 as a Therapeutic Target in Vincristine-Induced Peripheral Neuropathy - Paula Manuela Rojas Zambrano
- The ant with the electric sting: characterising pain-causing toxins from the venom of the electric ant (Wasmannia auropunctata) - Jia Hao Beh
- Mass spectrometry-guided discovery of gut-stable venom peptides - Rizana Azees
- Venom-derived blood-brain barrier peptide shuttles - Leonardo Marcazzan
- Venom-derived peptides to eradicate pathogenic gut biofilms - John Raju
- Arachnid venoms as a source of biocontrol for locust pest species - Katie Jee
- Venom peptides to study heart function and treat cardiovascular disease - Gabriel Osuna
- Investigating the role of TMEM233 in skeletal muscle using Excelsatoxin A - Anna Partridge
- Exploring the structure-activity relationship of pain-causing nettle peptides with TMEM233 and sodium channels - Qing Xu
- Venom peptide tracers for receptor imaging using modular signal amplification - Theresa Lehner
- Anti-Inflammatory Response of Venom Protein extracts from the Big Box Jellyfish Chironex fleckeri on Collagen Induced Arthritis (CIA) Murine Model - Rowena Thekkekara
Session 6: Keynote
Lunch
Free Time
Afternoon Tea
Session 7: Structure & Function
- Targeting peptide-activated class B1 GPCRs - Denise Wootten
- A Growth Factor Cystine Knot Peptide from Conus geographus with 5‑HT3 Receptor Antagonist Activity - Norelle L Daly
- Using deep-learning structure prediction and design critically in venom-to-drug discovery. - Katharine Michie
- Lipid partitioning is not required for high-affinity binding of gating modifier toxins to voltage-gated ion channels - Mehdi Mobli
Dinner at leisure
Poster Session
Sponsored by:
Evolutionary origins and diversification of peptide toxins in bee venoms - William Atherton (001)
Mass spectrometry-guided discovery of gut-stable venom peptides - Rizana Azees (002)
The ant with the electric sting: characterising pain-causing toxins from the venom of the electric ant (Wasmannia auropunctata) - Jia Hao Beh (003)
From ant venom to antibiofilm drug leads for treating gut disorders - Bernhard Jandl (004)
Arachnid venoms as a source of biocontrol for locust pest species - Katie Jee (005)
Resurgent-like currents induced by MoTxA as the cause of de novo sensory neuron cold hypersensitivity - Tabea Klasfauseweh (006)
Venom peptide tracers for receptor imaging using modular signal amplification - Theresa Lehner (007)
Venom-derived blood-brain barrier peptide shuttles - Leonardo Marcazzan (008)
Interaction of Kv1.3-specific peptide toxins with heterotetrameric Kv1 channels - Muhammad Umair Naseem (009)
From Tick Saliva to Precision Anti-Inflammatory Therapeutics: Engineering Selective Chemokine-Binding Proteins - Levi J Naunton (010)
Venom peptides to study heart function and treat cardiovascular disease - Gabriel Osuna (011)
Investigating the role of TMEM233 in skeletal muscle using Excelsatoxin A - Anna Partridge (012)
Venom-derived peptides to eradicate pathogenic gut biofilms - John Raju (013)
Genomic investigation of host / snake venom interactions - Mathew MS Samuel (014)
Investigating pain-causing toxins in plant venoms - Marie Tuifua (015)
Exploring arachnid venom peptides for biocontrol of pest snails - Yachen Wang (016)
Exploring the structure-activity relationship of pain-causing nettle peptides with TMEM233 and sodium channels - Qing Xu (017)
Investigating the Role of Kv1.3 as a Therapeutic Target in Vincristine-Induced Peripheral Neuropathy - Paula Manuela Rojas Zambrano (018)
Anti-Inflammatory Response of Venom Protein extracts from the Big Box Jellyfish Chironex fleckeri on Collagen Induced Arthritis (CIA) Murine Model - Thekkekara, Rowena (019)